Repligen reported $0.37 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.42 0.43 Nov/04 2025
FY2025Q2 Jun/2025 0.37 0.39 0.33 Jul/29 2025
FY2025Q1 Mar/2025 0.39 0.35 0.28 Apr/29 2025
FY2024Q4 Dec/2024 0.44 0.41 0.33 Feb/20 2025
FY2024Q3 Sep/2024 0.43 0.33 0.23 Nov/12 2024



Eps Change Date
Agilent USD 1.18 0.13 Jul/2025
Align Technology USD 2.49 0.36 Jun/2025
Bio Techne USD 0.53 0.03 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Bruker USD 0.32 0.15 Jun/2025
Charles River Laboratories USD 3.12 0.78 Jun/2025
Danaher USD 1.8 0.08 Jun/2025
Dentsply International USD 0.52 0.09 Jun/2025
Exact Sciences USD -0.01 0.53 Jun/2025
General Electric Aerospace USD 1.66 0.17 Jun/2025
Henry Schein USD 1.1 0.05 Jun/2025
Illumina USD 1.19 0.22 Jun/2025
IQVIA Holdings USD 2.81 0.11 Jun/2025
Mettler Toledo International USD 10.09 1.9 Jun/2025
Myriad Genetics USD 0.05 0.08 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Repligen USD 0.37 0.02 Jun/2025
Revvity USD 1.18 0.17 Jun/2025
Standard Biotools USD -0.05 0.04 Jun/2025
Thermo Fisher Scientific USD 5.36 0.21 Jun/2025
Waters USD 2.95 0.7 Jun/2025
West Pharmaceutical Services USD 1.84 0.39 Jun/2025